Avitide's Series E Round

Avitide raised a round of funding on June 21, 2017.

Avitide delivers on-demand, molecule-specific biopharmaceutical affinity purification solutions with an industry-leading 3-month service. Avitide's proprietary affinity separation technology enables o…

Articles about Avitide's Series E Round: